These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26906078)

  • 1. Stimulants for depression: On the up and up?
    Malhi GS; Byrow Y; Bassett D; Boyce P; Hopwood M; Lyndon W; Mulder R; Porter R; Singh A; Murray G
    Aust N Z J Psychiatry; 2016 Mar; 50(3):203-7. PubMed ID: 26906078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for psychostimulants in old age depression and apathy?
    Ng B
    Int Psychogeriatr; 2009 Apr; 21(2):417-8. PubMed ID: 19216822
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
    Carlson PJ; Merlock MC; Suppes T
    Bipolar Disord; 2004 Oct; 6(5):416-20. PubMed ID: 15383134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modafinil in the treatment of depression].
    Videbech P
    Ugeskr Laeger; 2012 Feb; 174(6):348-51. PubMed ID: 22310006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the use of stimulants and stimulant alternatives in treating bipolar depression and major depressive disorder.
    Corp SA; Gitlin MJ; Altshuler LL
    J Clin Psychiatry; 2014 Sep; 75(9):1010-8. PubMed ID: 25295426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do the old psychostimulant drugs have a role in managing treatment-resistant depression?
    Parker G; Brotchie H
    Acta Psychiatr Scand; 2010 Apr; 121(4):308-14. PubMed ID: 19594481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychostimulants for managing unipolar and bipolar treatment-resistant melancholic depression: a medium-term evaluation of cost benefits.
    Parker G; Brotchie H; McClure G; Fletcher K
    J Affect Disord; 2013 Oct; 151(1):360-4. PubMed ID: 23810360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
    Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis.
    McIntyre RS; Lee Y; Zhou AJ; Rosenblat JD; Peters EM; Lam RW; Kennedy SH; Rong C; Jerrell JM
    J Clin Psychopharmacol; 2017 Aug; 37(4):412-418. PubMed ID: 28590365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of dopaminergic and stimulant drugs for the treatment of depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):11-4. PubMed ID: 22263621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of stimulants in depression: Results from a self-controlled register study.
    Rohde C; Brink P; Østergaard SD; Nielsen J
    Aust N Z J Psychiatry; 2020 Aug; 54(8):808-817. PubMed ID: 32447969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
    J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of adjunctive stimulants in adult bipolar depression.
    Dell'Osso B; Ketter TA
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):55-68. PubMed ID: 22717304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate and depression.
    Ng B
    J Clin Psychopharmacol; 2008 Feb; 28(1):116-7; author reply 117-8. PubMed ID: 18204360
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of psychostimulants in cancer patients.
    Portela MA; Rubiales AS; Centeno C
    Curr Opin Support Palliat Care; 2011 Jun; 5(2):164-8. PubMed ID: 21532350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials.
    Abbasowa L; Kessing LV; Vinberg M
    Nord J Psychiatry; 2013 Dec; 67(6):369-82. PubMed ID: 23293898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil add-on in the treatment of bipolar depression.
    Belmaker RH
    Am J Psychiatry; 2007 Aug; 164(8):1143-5. PubMed ID: 17671273
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulants for treating bipolar disorder: pro and con.
    Grunze H
    Harv Rev Psychiatry; 2014; 22(6):358-62. PubMed ID: 25377610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and dysphoria effects on the interpersonal perception of negative and positive moods and caring relationships: effects of antidepressants, amphetamine, and methylphenidate.
    Janowsky DS
    Curr Psychiatry Rep; 2003 Dec; 5(6):451-9. PubMed ID: 14609500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
    Lam JY; Freeman MK; Cates ME
    Ann Pharmacother; 2007 Jun; 41(6):1005-12. PubMed ID: 17519297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.